
Rachael Sirianni
My primary expertise is in the field of central nervous system drug delivery, balances preclinical and translational work to develop new therapies in oncology, neuroprotection, and brain injury. My laboratory's research activities includes formulation of drug loaded nanoparticles, imaging of nanoparticle transport, nanoparticle targeting, tissue engineering in the central nervous system, and intrathecal drug delivery.
Latest articles by Rachael Sirianni

Trump 2.0 is dismantling American science. Here's what's at stake, according to researchers.
By Carrie McDonough, Brian G. Henning, Cara Poland, Nathaniel M. Tran, Rachael Sirianni, Stephanie J. Nawyn published
Opinion U.S.-based researchers detail how their work has been disrupted by funding cuts and policy changes ushered by the second Trump administration.
Get the world’s most fascinating discoveries delivered straight to your inbox.
